shannah
Senior Member
- Messages
- 1,429
PatentIAGNOSIS AND TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH XENOTROPIC MURINE LEUKEMIA VIRUS
.by XMRV Global Action on Tuesday, December 28, 2010 at 12:05pm.Patent application Published on 12/23/2010
(WO/2010/148323) DIAGNOSIS AND TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH XENOTROPIC MURINE LEUKEMIA VIRUS
Pub. No.: WO/2010/148323 International Application No.: PCT/US2010/039208
Publication Date: 23.12.2010 International Filing Date: 18.06.2010
IPC: C12Q 1/70 (2006.01)
Applicants: WHITTEMORE PETERSON INSTITUTE FOR NEURO-IMMUNE DISEASE [US/US]; 6600 N. Wingfield Parkway Sparks, Nevada 89436 (US) (All Except US).
MIKOVITS, Judy, A. [US/US]; (US) (US Only).
LOMBARDI, Vincent, C. [US/US]; (US) (US Only).
RUSCETTI, Sandra, K. [US/US]; (US) (US Only).
RUSCETTI, Francis, W. [US/US]; (US) (US Only).
Inventors: MIKOVITS, Judy, A.; (US).
LOMBARDI, Vincent, C.; (US).
RUSCETTI, Sandra, K.; (US).
RUSCETTI, Francis, W.; (US).
Title: DIAGNOSIS AND TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH XENOTROPIC MURINE LEUKEMIA VIRUS
Abstract: <!-- if (drawingString != 'NULL') { self.document.writeln(drawingString); } else { self.document.writeln("") } // -->Methods of detecting, diagnosing, monitoring or managing an XMRV-related neuroimmune disease such as chronic fatigue syndrome or XMRV-related lymphoma such as mantle cell lymphoma in a subject are disclosed. These methods comprise determining presence, absence or quantity an XMRV immunopeptide, an XMRV antigen, or an XMRV nucleic acid in a sample from a subject. Therapeutic methods of treatment with anti-retroviral agents are also disclosed. Further disclosed are assays for testing compounds having activity against XMRV.
.
.by XMRV Global Action on Tuesday, December 28, 2010 at 12:05pm.Patent application Published on 12/23/2010
(WO/2010/148323) DIAGNOSIS AND TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH XENOTROPIC MURINE LEUKEMIA VIRUS
Pub. No.: WO/2010/148323 International Application No.: PCT/US2010/039208
Publication Date: 23.12.2010 International Filing Date: 18.06.2010
IPC: C12Q 1/70 (2006.01)
Applicants: WHITTEMORE PETERSON INSTITUTE FOR NEURO-IMMUNE DISEASE [US/US]; 6600 N. Wingfield Parkway Sparks, Nevada 89436 (US) (All Except US).
MIKOVITS, Judy, A. [US/US]; (US) (US Only).
LOMBARDI, Vincent, C. [US/US]; (US) (US Only).
RUSCETTI, Sandra, K. [US/US]; (US) (US Only).
RUSCETTI, Francis, W. [US/US]; (US) (US Only).
Inventors: MIKOVITS, Judy, A.; (US).
LOMBARDI, Vincent, C.; (US).
RUSCETTI, Sandra, K.; (US).
RUSCETTI, Francis, W.; (US).
Title: DIAGNOSIS AND TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH XENOTROPIC MURINE LEUKEMIA VIRUS
Abstract: <!-- if (drawingString != 'NULL') { self.document.writeln(drawingString); } else { self.document.writeln("") } // -->Methods of detecting, diagnosing, monitoring or managing an XMRV-related neuroimmune disease such as chronic fatigue syndrome or XMRV-related lymphoma such as mantle cell lymphoma in a subject are disclosed. These methods comprise determining presence, absence or quantity an XMRV immunopeptide, an XMRV antigen, or an XMRV nucleic acid in a sample from a subject. Therapeutic methods of treatment with anti-retroviral agents are also disclosed. Further disclosed are assays for testing compounds having activity against XMRV.
.